• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆脂瘤的发病率、10年复发率及预后因素

Incidence, 10-year recidivism rate and prognostic factors for cholesteatoma.

作者信息

Britze A, Møller M L, Ovesen T

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery,Aarhus Universitetshospital,Denmark.

Department of Clinical Medicine,Aarhus University,Denmark.

出版信息

J Laryngol Otol. 2017 Apr;131(4):319-328. doi: 10.1017/S0022215117000299.

DOI:10.1017/S0022215117000299
PMID:28244845
Abstract

OBJECTIVE

Cholesteatoma patients have a high risk of recurrence with complications, and knowledge exchange is a prerequisite for improving treatment. This study aimed to apply appropriate statistics to provide meaningful and transferable results from cholesteatoma surgery, to highlight independent prognostic factors, and to assess the incidence rate.

METHODS

Incidence rates were assessed for the district of Aarhus, Denmark. From 147 patients operated on mainly with canal wall up mastoidectomies for debuting cholesteatomas, 10-year Kaplan-Meier recidivism rates were calculated and independent prognostic factors for the recidivism were identified by Cox multivariate regression analyses.

RESULTS

Incidence rate was 6.8 per 100 000 per year. The 10-year cumulative recidivism rate was 0.44 (95 per cent confidence interval, 0.37-0.53). Independent prognostic factors for the recidivism were: age below 15 years (hazard ratio = 2.2; p > z = 0.002), cholesteatoma localised to the mastoid (hazard ratio = 1.7; p > z = 0.04), stapes erosion (hazard ratio = 1.9; p > z = 0.02) and incus erosion (hazard ratio = 1.9; p > z = 0.04).

CONCLUSION

The recidivism rate is influenced by several factors that are important to observe, both in the clinic and when comparing results from surgery.

摘要

目的

胆脂瘤患者复发并伴有并发症的风险很高,知识交流是改善治疗的前提条件。本研究旨在应用适当的统计学方法,以提供来自胆脂瘤手术的有意义且可推广的结果,突出独立的预后因素,并评估发病率。

方法

对丹麦奥胡斯地区的发病率进行了评估。从147例主要接受开放式乳突根治术治疗初发性胆脂瘤的患者中,计算了10年的Kaplan-Meier复发率,并通过Cox多变量回归分析确定了复发的独立预后因素。

结果

年发病率为每10万人中6.8例。10年累积复发率为0.44(95%置信区间,0.37 - 0.53)。复发的独立预后因素为:年龄低于15岁(风险比 = 2.2;p>z = 0.002),胆脂瘤局限于乳突(风险比 = 1.7;p>z = 0.04),镫骨侵蚀(风险比 = 1.9;p>z = 0.02)和砧骨侵蚀(风险比 = 1.9;p>z = 0.04)。

结论

复发率受多种因素影响,这些因素在临床以及比较手术结果时都很重要,值得关注。

相似文献

1
Incidence, 10-year recidivism rate and prognostic factors for cholesteatoma.胆脂瘤的发病率、10年复发率及预后因素
J Laryngol Otol. 2017 Apr;131(4):319-328. doi: 10.1017/S0022215117000299.
2
Cholesteatoma: ossicular destruction in adults and children.胆脂瘤:成人和儿童的听小骨破坏
J Laryngol Otol. 1994 Jul;108(7):541-4. doi: 10.1017/s0022215100127380.
3
Surgical treatment of pediatric cholesteatomas.小儿胆脂瘤的外科治疗。
Laryngoscope. 2006 Sep;116(9):1603-7. doi: 10.1097/01.mlg.0000233248.03276.9b.
4
Mastoid obliteration for pediatric suppurative cholesteatoma: long-term safety and sustained effectiveness after 30 years' experience with cartilage obliteration.儿童化脓性胆脂瘤的乳突腔闭塞术:30年软骨闭塞术经验后的长期安全性和持续有效性
Audiol Neurootol. 2014;19(6):358-69. doi: 10.1159/000363685. Epub 2014 Nov 4.
5
External auditory canal cholesteatoma and benign necrotising otitis externa: clinical study of 95 cases in the Capital Region of Denmark.外耳道胆脂瘤与良性坏死性外耳道炎:丹麦首都地区95例临床研究
J Laryngol Otol. 2018 Jun;132(6):514-518. doi: 10.1017/S0022215118000750. Epub 2018 Jun 11.
6
Prognostic factors of recidivism in pediatric cholesteatoma surgery.小儿胆脂瘤手术复发的预后因素
Int J Pediatr Otorhinolaryngol. 2003 Dec;67(12):1325-30. doi: 10.1016/j.ijporl.2003.08.002.
7
[Acquired pediatric cholesteatoma: predictive factors of recurrence. A retrospective study of 11 years].[获得性小儿胆脂瘤:复发的预测因素。一项为期11年的回顾性研究]
J Med Liban. 2014 Jan-Mar;62(1):7-13.
8
How long is long enough to follow up children after cholesteatoma surgery? A 29-year study.胆脂瘤手术后需要随访儿童多长时间?一项长达 29 年的研究。
Laryngoscope. 2012 Nov;122(11):2568-73. doi: 10.1002/lary.23510. Epub 2012 Aug 1.
9
Time Analysis of Recidivism in Acquired Cholesteatoma Using the Kaplan-Meier Method.采用 Kaplan-Meier 法分析后天性胆脂瘤复发的时间分析。
Otol Neurotol. 2023 Jul 1;44(6):e393-e397. doi: 10.1097/MAO.0000000000003908. Epub 2023 May 28.
10
Ear canal cholesteatoma.外耳道胆脂瘤
Laryngoscope. 1992 Jun;102(6):608-13. doi: 10.1288/00005537-199206000-00004.

引用本文的文献

1
Identification of Differential Metabolites in Chronic Suppurative Otitis Media With Non-Targeted and Targeted Metabolomics Approach.基于非靶向和靶向代谢组学方法鉴定慢性化脓性中耳炎中的差异代谢物
Smart Med. 2025 Jul 30;4(3):e70015. doi: 10.1002/smmd.70015. eCollection 2025 Sep.
2
ROS-responsive adaptive injectable hydrogel promoting inflammatory mastoid bone repair through efficient sterilization and regulating oxidative stress and macrophage phenotype.ROS响应性自适应可注射水凝胶通过高效杀菌、调节氧化应激和巨噬细胞表型促进炎性乳突骨修复。
Mater Today Bio. 2025 May 14;32:101856. doi: 10.1016/j.mtbio.2025.101856. eCollection 2025 Jun.
3
Exclusive endoscopic tympanoplasty efficacy in the treatment of cholesteatoma without mastoid involvement.
单纯内镜鼓室成形术治疗不伴乳突病变胆脂瘤的疗效。
Eur Arch Otorhinolaryngol. 2024 Nov;281(11):5669-5675. doi: 10.1007/s00405-024-08778-8. Epub 2024 Sep 26.
4
MRI-DWI detection of residual cholesteatoma: moving toward an optimum follow-up scheme.磁共振成像扩散加权成像(MRI-DWI)检测残余胆脂瘤:迈向最佳随访方案
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):659-668. doi: 10.1007/s00405-024-08939-9. Epub 2024 Sep 13.
5
Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.骨桥蛋白驱动的部分上皮-间充质转化控制中耳胆脂瘤的发生。
Cell Cycle. 2024 Mar;23(5):537-554. doi: 10.1080/15384101.2024.2345481. Epub 2024 Apr 25.
6
Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma.人胆脂瘤个体发育过程中组织因子的比较
Diagnostics (Basel). 2024 Mar 21;14(6):662. doi: 10.3390/diagnostics14060662.
7
Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear.克服障碍:中耳和内耳药物递送创新综述
Front Pharmacol. 2023 Oct 19;14:1207141. doi: 10.3389/fphar.2023.1207141. eCollection 2023.
8
Expression and Regulatory Mechanisms of MicroRNA in Cholesteatoma: A Systematic Review.胆脂瘤中 microRNA 的表达和调控机制:系统评价。
Int J Mol Sci. 2023 Jul 31;24(15):12277. doi: 10.3390/ijms241512277.
9
The Impact of Chronic Suppurative Otitis Media with and without Cholesteatoma in Patients from Northeastern Romania.罗马尼亚东北部慢性化脓性中耳炎伴或不伴胆脂瘤患者的影响
Healthcare (Basel). 2022 Dec 27;11(1):73. doi: 10.3390/healthcare11010073.
10
Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study.开放式乳突根治鼓室成形术治疗鼓室乳突胆脂瘤的长期解剖学及听力结果:一项20年回顾性研究
Life (Basel). 2022 Oct 31;12(11):1745. doi: 10.3390/life12111745.